The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2020
Filed:
May. 31, 2018
Applicant:
Eli Lily and Company, Indianapolis, IN (US);
Inventors:
Mansuo Lu Hayashi, Carmel, IN (US);
Jirong Lu, Carmel, IN (US);
David Driver, Solana Beach, CA (US);
Alberto Alvarado, San Diego, CA (US);
Assignee:
Eli Lilly and Company, Indianapolis, IN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C07H 21/00 (2006.01); C07H 19/00 (2006.01); C12N 15/00 (2006.01); C12N 15/09 (2006.01); C12N 15/10 (2006.01); A61K 39/395 (2006.01); A61K 49/00 (2006.01); A61K 49/16 (2006.01); C12P 21/00 (2006.01); C12P 21/02 (2006.01); C07K 16/18 (2006.01); C07K 16/00 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); A61K 51/10 (2006.01); C07K 14/435 (2006.01); C07K 14/47 (2006.01); G01N 33/68 (2006.01); G01N 33/577 (2006.01); G01N 33/573 (2006.01); C12N 5/07 (2010.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 49/16 (2013.01); C07K 16/00 (2013.01); C12N 15/00 (2013.01); C12N 15/09 (2013.01); C12N 15/10 (2013.01); A01K 2267/0318 (2013.01); A61K 39/0005 (2013.01); A61K 39/0007 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 49/0058 (2013.01); A61K 51/1018 (2013.01); A61K 2039/505 (2013.01); C07H 21/00 (2013.01); C07H 21/04 (2013.01); C07K 14/435 (2013.01); C07K 14/47 (2013.01); C07K 14/4711 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C12N 5/06 (2013.01); C12N 5/0602 (2013.01); C12P 21/00 (2013.01); C12P 21/02 (2013.01); G01N 33/573 (2013.01); G01N 33/577 (2013.01); G01N 33/6854 (2013.01); G01N 33/6896 (2013.01); G01N 2800/28 (2013.01); G01N 2800/2814 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01); Y10S 424/80 (2013.01);
Abstract
Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.